arrow
B

Beatrice Taurelli Salimbeni

European Institute of Oncology
H指数:10
被引数:487

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Breast Cancer on Sexuality and Psycho-Physical Wellbeing: Survey Analysis

乳腺癌对性功能和身心健康的影晌:调查分析

2026-03-090
OAAI
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group

浸润性小叶癌:小叶性乳腺癌研究小组的策略与展望

2025-08-070
OAAI
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies

克服激素受体阳性、HER2阴性乳腺癌对CDK4/6抑制剂的耐药性:创新联合疗法与新兴策略

2025-06-140
OAAI
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment

HER2+转移性乳腺癌接受一线治疗时肿瘤浸润淋巴细胞对预后的影响

2025-05-100
OA
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology

放射性配体疗法在转移性乳腺癌中的应用:利用精准肿瘤学

2025-05-010
OAAI
Molecular tumor board in patients with metastatic breast cancer

转移性乳腺癌患者的分子肿瘤板

2024-10-301
PRE
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (vol 10, 58, 2024)

药物-药物相互作用对abemaciclib在AB-意大利研究的真实世界经验中的临床影响 (第10卷,58卷,2024)

2024-08-020
OAAI
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer

雌激素受体低和阴性早期乳腺癌的免疫和基因表达谱

2024-07-312
OAAI
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study

在AB-意大利研究的现实世界经验中,药物-药物相互作用对abemaciclib的临床影响

2024-07-173
OAAI
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
2023-12-010
PRE
Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients with Chest Wall Breast Cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1)
2023-03-010
PRE
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

Paner研究: 一项来自真实世界环境的HER2-positive晚期乳腺癌患者的多中心观察性研究的20年治疗结果分析

2021-11-296
OAAI